[What do we think about selective estrogen receptor modulators?].
作者信息
Cortet B
出版信息
Rev Med Interne. 2001 Dec;22(12):1173-6. doi: 10.1016/s0248-8663(01)00487-8.
Abstract
摘要
相似文献
1
[What do we think about selective estrogen receptor modulators?].我们对选择性雌激素受体调节剂有什么看法？
Rev Med Interne. 2001 Dec;22(12):1173-6. doi: 10.1016/s0248-8663(01)00487-8.
2
[Hormone replacement and selective estrogen receptor modulators (SERMS) in the prevention and treatment of postmenopausal osteoporosis].[激素替代疗法及选择性雌激素受体调节剂（SERMs）在绝经后骨质疏松症防治中的应用]
Orthopade. 2001 Jul;30(7):462-72. doi: 10.1007/s001320170079.
3
Selective estrogen receptor modulators.
Climacteric. 1998 Jun;1(2):143-7. doi: 10.3109/13697139809085530.
4
[SERM for early osteoporosis therapy. Risk for first spinal fracture reduced to half].
MMW Fortschr Med. 2003 May 29;145(22):57.
5
[Treatment of postmenopausal osteoporosis with raloxifene].雷洛昔芬治疗绝经后骨质疏松症
Bratisl Lek Listy. 2000;101(9):527-8.
6
Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial. Multiple outcomes of raloxifene evaluation.雷洛昔芬治疗绝经后女性持续降低乳腺癌风险：MORE试验的4年结果。雷洛昔芬评估的多项结果。
Breast Cancer Res Treat. 2001 Jan;65(2):125-34. doi: 10.1023/a:1006478317173.
7
[Molecular mechanism tissue-specific actions of selective estrogen receptor modulators].
Nihon Ronen Igakkai Zasshi. 2006 Mar;43(2):147-51. doi: 10.3143/geriatrics.43.147.
8
CORE breast-cancer prevention trial.
Lancet Oncol. 2005 Jan;6(1):8. doi: 10.1016/s1470-2045(04)01700-0.
9
Raloxifene examined for breast cancer prevention.对雷洛昔芬进行乳腺癌预防研究。
Am J Health Syst Pharm. 2007 Sep 1;64(17):1774. doi: 10.2146/news070075.
10
The role of selective estrogen receptor modulators in the prevention and treatment of osteoporosis.选择性雌激素受体调节剂在骨质疏松症预防和治疗中的作用。
Rheum Dis Clin North Am. 2001 Feb;27(1):163-85, vii. doi: 10.1016/s0889-857x(05)70192-7.
Zotero 插件